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ABSTRACT
RNA-Seq (Nagalakshmi, et al., 2008; Mortazavi, et al., 2008), also known as Whole
transcriptome sequencing investigates the RNA content from a sample through high throughput
sequencing of cDNA. This exciting technology has important applications such as the
improvement of existing genome annotations, discovery of novel genes and transcripts (Roberts,
et al., 2011), revealing alternative splicing events and measuring the differential expression of
genes across samples. This study examines the transcriptional responses of B-cells to the
influenza vaccine using RNA-Seq. Five subjects received the flu vaccine. RNA was extracted at
11 different time points and sequenced using RNA-Seq. The RNA-Seq data was aligned to the
reference genome using Tophat. The aligned reads were assembled into transcripts and the
differential expression of the transcripts was measured across the samples using Cufflinks. The
resultant data was analyzed by a downstream analysis algorithm to only select for “novel” genes
that correlate with well-annotated genes known to be important in immunity. This analysis led to
the selection of two “novel” genes that that are most likely to be of interest for further functional
characterization.

iv

LIST OF FIGURES
FIGURE 2.1: AN OVERVIEW OF THE PROTOCOL ………………………………………………………………………………………11
FIGURE 2.2: TOPHAT WORKFLOW …………………………………………………………………………………………………………13
FIGURE 2.3: CUFFLINKS WORKFLOW ……………………………………………………………………………………………………..16
FIGURE 2.4: RABT ASSEMBLY …………………………………………………………………………………………………….............17
FIGURE 2.5: CUFFMERGE ASSEMBLY ……………………………………………………………………………………………………..20
FIGURE 2.6: IDENTIFY DIFFERENTLY REGULATED GENES USING CUFFDIFF …………………………………………….23
FIGURE 3.1: EFFECT OF FILTERS IN DOWNSTREAM ANALYSIS ………………………………………………………………..30
FIGURE 3.2: DISTRIBUTION OF FPKM OF CANDIDATE GENES IN SUBJECTS 1, 2 AND 3 …………………………….31
FIGURE 3.3: BLASTN HITS FOR GENE 3 ………………………………………………………………………………….….…………..32
FIGURE 3.4: VIEW OF GENE 2 ON UCSC GENOME BROWSER …………………………………………………………………33
FIGURE 3.5: PLOT OF FINAL GENE 1 ON IGV ………………………………………………………………………………………….34
FIGURE 3.6: PLOT OF FINAL GENE 2 ON IGV ………………………………………………………………………………………….34
FIGURE 3.7: DISTRIBUTION OF FPKM OF MDM1 AND IL22 ……………………………………………………………………35
FIGURE 3.8: DISTRIBUTION OF FPKM OF ANG AND RNASE4 (OVERLAPPING GENES) …………………………..35

v

LIST OF TABLES
TABLE 1.1: HEADER SECTION OF SAM FILE ………………………………………………………………………………………………4
TABLE 1.2: ALIGNMENT SECTION OF SAM FILE ……………………………………………………………………………………….5
TABLE 1.3: FASTQ FORMAT …………………………………………………………………………………………………………………….6
TABLE 2.1: TOPHAT PARAMETERS USED IN THE ANALYSIS …………………………………………………………………….14
TABLE 2.2: CUFFLINKS PARAMETERS USED IN ANALYSIS ………………………………………………………………………18
TABLE 2.3: CUFFMERGE PARAMETERS USED IN THE ANALYSIS …………………………………………………………….21
TABLE 2.4: CUFFDIFF PARAMETERS USED IN THE ANALYSIS …………………………………………………………………24
TABLE 3.1: EFFECT OF FILTERS IN DOWNSTREAM ANALYSIS ………………………………………………………………..29
TABLE 3.2: THE FIVE CANDIDATE GENES ………………………………………………………………………………………………30

vi

DEDICATION

To the Almighty and my loving family.

vii

ACKNOWLEDGEMENTS

I am grateful for all support from Dr. Stephen Welle, Dr. Gary Skuse, Dr.
Michael Osier, Dr. Anne Haake and the Bioinformatics Program.

viii

Table of Contents
LIST OF FIGURES .............................................................................................................................. IV
LIST OF TABLES .................................................................................................................................V
1 INTRODUCTION ........................................................................................................................... 1
1.1 RNA-SEQUENCING ..................................................................................................................... 1
1.2 ILLUMINA SEQUENCING ............................................................................................................... 3
1.2.1 LIBRARY PREPARATION ......................................................................................................... 3
1.2.2 CLUSTER GENERATION .......................................................................................................... 3
1.2.3 SEQUENCING BY SYNTHESIS ................................................................................................... 3
1.3 FILE FORMAT ............................................................................................................................. 4
1.3.1 SAM/BAM FILES ............................................................................................................... 4
1.3.2 FASTQ ............................................................................................................................. 6
1.3.3 QUALITY SCORES ................................................................................................................. 7
2 MATERIALS AND METHODS......................................................................................................... 8
2.1 EXPERIMENT.............................................................................................................................. 8
2.2 ENVIRONMENT SETUP.................................................................................................................. 8
2.2.1 BOWTIE ............................................................................................................................. 8
2.2.2 SAM TOOLS ....................................................................................................................... 9

ix
2.2.3 TOPHAT ............................................................................................................................. 9
2.2.4 CUFFLINKS ......................................................................................................................... 9
2.2.5 REFERENCE GENOME ............................................................................................................ 9
2.3 PROTOCOL ............................................................................................................................. 9
2.3.1 ALIGN RNA-SEQ READS USING TOPHAT ................................................................................. 11
2.3.2 ASSEMBLE TRANSCRIPTS FOR EACH TIME POINT USING CUFFLINKS ............................................... 15
2.3.3 MERGE INDIVIDUAL ASSEMBLIES USING CUFFMERGE................................................................. 20
2.3.4 IDENTIFY DIFFERENTIALLY EXPRESSED GENES AND TRANSCRIPTS USING CUFFDIFF............................. 22
2.3.5 DOWNSTREAM ANALYSIS ALGORITHM ................................................................................... 25
3 RESULTS AND DISCUSSION ........................................................................................................ 29
4 CONCLUSION.............................................................................................................................. 37
5 REFERENCES ............................................................................................................................... 38

1

1 INTRODUCTION
1.1 RNA-Sequencing
Transcriptome analysis is essential for understanding the functional elements of the genome,
molecular constituents of the cells and tissue, cell development, cell fate and disease progression
(Mortazavi, et al., 2008). It is gaining importance in the study of changing expression levels of
transcripts under different disease conditions such as cancer, diabetes and heart disease. Arraybased, tag-based and next generation sequencing approaches are the most common technologies
that have been used to quantify the transcriptome.
Array-based methods typically involve hybridization of fluorescently labeled cDNA with probes
using custom-made microarrays or oligo-microarrays. Unfortunately they are constrained by
limitations such as cross-hybridization, the need for prior knowledge about the genome
sequence, poor sensitivity for less abundant transcripts, the need for complex normalization
methods in order to compare expression across samples. These issues have made it difficult for
the arrays to detect RNA splice patterns, novel transcripts and to provide full sequence coverage.
Whole genome tiling microarrays are designed to probe for both coding and non-coding regions
of the entire genome. In contrast to the regular microarrays, these identify novel transcripts and
exons but require large amount of input RNA and difficulties in data analysis (Marioni, et al.,
2008).
Tag based methods such as serial analysis of gene expression (SAGE), massively parallel
signature sequencing (MPSS), cap analysis of gene expression (CAGE) which involve
sequencing of the cloned tags from terminal 3‟ or 5‟ sequence tags and then mapping to a
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reference genome or mRNA database. They are high throughput; provide digital counts of
transcripts and are more sensitive than the array based methods. However they suffer from the
ambiguity of uniquely mapping short tags to the reference genome and cannot be used to
examine splicing events.
Next generation sequencing methods are the best fit for genome analysis because they generate a
large number of short sequencing reads quickly, cheaply and from a smaller input of DNA or
RNA. Next-generation methods have provided a method for transcriptome analysis called RNA
Sequencing or simply RNA-Seq. Though microarrays have dominated the profiling of mRNAs
for more than a decade, RNA-Seq has the potential to overcome the limitations of microarrays.
RNA-Seq is very helpful in studying complex transcriptomes, alternative splicing, identifying
novel genes and exons and quantifying transcriptome composition with high sensitivity and
reproducibility (Mortazavi, et al., 2008).
In general, poly (A) mRNA is isolated from the total RNA. The mRNA is converted to a library
of cDNA fragments through either RNA fragmentation or DNA fragmentation with sequencing
adaptors attached to either one or both ends of the fragments. Each fragment is then deep
sequenced to obtain short sequences called „reads‟ either from one or both ends of the fragment,
called single-end and paired-end sequencing respectively. The reads are then aligned to the
reference genome or assembled de novo and used for transcriptional analysis. Any high
throughput sequencing technology such as Illumina‟s Genome Analyzer, Applied Biosystems‟s
SOLiD, Roche‟s 454, Helicos Biosciences‟s Heliscope can be used for RNA-Seq (Marioni, et al.,
2008).
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1.2 Illumina Sequencing
Sequencing using the Illumina Genome Analyzer work flow consists of three important steps: a)
library preparation b) cluster generation c) sequencing by synthesis.
1.2.1 Library Preparation
Poly (A) mRNA is isolated from the total RNA population and fragmented using a nebulizer or
sonication to obtain fragments of length less than 800 bp. It then undergoes the first and secondstrand synthesis using random hexamer priming to produce double stranded cDNA. The bluntended fragments are generated and prepared for ligation to the sequencing adaptors. These
adaptors contain the full complement of the sequencing primers. The final product created after
denaturation and amplification steps is ready for cluster generation. (TruSeq RNA and DNA
Sample Preparation Kits v2, 2011)
1.2.2 Cluster generation
Size selected DNA from the library is annealed to the complementary PCR primers on the
surface of the flow cell. Addition of nucleotides and enzymes initiates solid-phase bridge
amplification. Several million clusters of amplicons are generated in each channel of the flow
cell. (Illumina Sequencing Technology, 2010)
1.2.3 Sequencing by Synthesis
The sequencing cycle begins with the addition of primers, fluorescently labeled reversible
terminators and DNA polymerase. Laser excitation captures the emitted fluor from each cluster
and the first base is identified. The cycles are repeated multiple times to determine the sequence
of the bases in a fragment one base at a time (Illumina Sequencing Technology, 2010).
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1.3 File Format
1.3.1 SAM/BAM files

SAM stands for Sequence Alignment /Map. It is a text format for storing large nucleotide
sequence data and alignments. SAM file formats are usually the output from mapping tools and
aligners that read FASTQ files and align the reads to a reference genome. BAM file format is the
binary version of SAM. A SAM file is a tab delimited text format that contains a Header section
and an Alignment section. The header section contains generic information about the entire file.
It starts with @ followed by a two letter record type code. Each data field is of the format TAG:
VALUE where TAG is a two letter string that defines the content and the format of VALUE.
The following table shows the list of record types and their mandatory tags (Table 1).
Record type

Record Description

Tag

Tag description

@HD

Header line

VN

Format version

@SQ

Reference sequence dictionary

SN

Reference sequence name

LN

Reference sequence length

@RG

Read group

ID

Read group identifier

@PG

Program

ID

Program record identifier

@CO

One line text comment

Table 1.1: Header section of SAM file
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The alignment section shows the alignment of the sequenced reads to the reference genome and
also the quality of alignment. It contains 11 mandatory fields. All 11 fields must be present, but
with a value of 0 or * if the corresponding information is not available and must always appear in
the same order. The following table describes the alignment fields and their description (Table
1.2).
Column

Field

Type

Description

1

QNAME

String

Query template name

2

FLAG

Int

Bitwise flag

3

RNAME

String

Reference sequence name

4

POS

Int

1-based leftmost mapping position

5

MAPQ

Int

Mapping quality

6

CIGAR

String

CIGAR string

7

RNEXT

String

Ref name of next segment

8

PNEXT

Int

Position of next segment

9

TLEN

Int

Observed template length

10

SEQ

String

Segment sequence

11

QUAL

String

Phred scale based quality + 33

Table 1.2: Alignment section of SAM file
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1.3.2 FASTQ

FASTQ format (Cock, et al., 2010) is a common text-based format for storing sequence data and
its quality score. It is a simple extension to the FASTA format with the addition of the numeric
quality score. This has become a common format for sharing sequencing read data between tools.
FASTQ is also the standard for storing the output of high throughput sequencing instruments
such as the Illumina Genome Analyzer.
The format consists of 4 line types per sequence (Table 1.3). The first line is the title line. It
starts with a „@‟ and contains the sequence identifier and optional description. The second line is
the sequence line which contains the actual sequence information. The third line starts with a „+‟
that signals the end of the sequence line. It optionally includes the full repeat of the text in the
title line. The last line called the quality line contains the quality values that are single-byte
encoded. The length of the quality line is the same as that of the sequence line with a score for
each letter in the sequence.
Line
Num

Line Description

Example

1

@title line

@ HWUSI-EAS100R:7:77:979:1973#0/1

2

Sequence line

GGGTGATGGCCGCTGCCGATGGCGTCAAATCCCACC

3

+ optional repeat of title line

+ HWUSI-EAS100R:7:77:979:1973#0/1

4

Quality line

!''*((((***+))%%%++)(%%%%).1***+*''))**55CCF>>>>>>CCCCCCC65

Table 1.3: FASTQ format
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1.3.3 Quality Scores
A quality score Q is the measure of the base calling accuracy. Base calling error probability (P)
is the probability that a given base is called incorrectly by the sequencer. The Q score is a metric
that is logarithmically related to P.
The PHRED quality score Q is defined as:
QPHRED = -10 * log10 (p)
For example: A PHRED score of 10 is equivalent to the probability of an incorrect base call 1 in
10 times. Thus the base call accuracy is 90%. This means that there might be an error in every 10
bp read. A score of 20 means that 1 in 100bp is likely to contain an error and a score of 30 means
that 1 in 1000bp is likely to have an error, so on and so forth. Thus, Q30 ensures 99.9% accuracy
which is considered to be the bench mark for quality in next-generation sequencing. Lower base
calls increases the quality of false positive base calls (Quality Scores for Next-Generation
Sequencing, 2011).
The Solexa quality score is calculated from the odds p/ (1-p) instead of the error probability p:
QSolexa = -10 * log10 (p/1-p)
This score was generated from the Illumina pipeline prior to v.1.3.
The Q scores are encoded as bytes using ASCII characters 33 to 126 in Sanger FASTQ files for
PHRED quality values (offset of 33) from 0 to 93. Solexa FASTQ files use ASCII characters 59
to 126 for Solexa scores (offset of 64) from -5 to 62. Illumina 1.3+ FASTQ files use ASCII
characters 64 to 126 for PHRED scores (offset of 64) from 0 to 62.
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2 MATERIALS AND METHODS
2.1 Experiment
Five subjects were vaccinated with the trivalent influenza vaccine that was administered to the
US population in 2010. Blood samples were taken immediately before the vaccine, then every
day for the next 10 days. Peripheral blood mononuclear cells (PBMC) and B-cell fractions were
pulled from the blood and RNA was extracted from these cells. Each subject had data for 11 time
points starting from day0 to day10.The samples were prepared for sequencing with Illumina
TruSeq RNA library preparation kit (TruSeq RNA and DNA Sample Preparation Kits v2, 2011).
The resulting cDNA libraries were then sequenced using an Illumina Genome Analyzer IIx
(Illumina Sequencing Technology, 2010). The sequenced read data, stored as FASTQ files are
used in the downstream analysis of the data.
Only 3 of the 5 subjects were included in the analysis. Based on the analysis by Dr. Martin
Zand‟s lab at UR medical center, these 3 subjects had strong "immune memory" responses and
their gene expression response pattern was different than that of the 2 subjects with weak
immune memory responses.

2.2 Environment setup
The RNA-Seq data analysis was done using open-source software Tophat and Cufflinks. The
Bowtie and SAM tools are needed for the installation of Tophat and Cufflinks.
2.2.1 Bowtie
Bowtie software was downloaded from http://sourceforge.net/projects/bowtie-bio/files/bowtie2/
and extracted to a Linux server.
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2.2.2 SAM tools
The SAM tools were downloaded from http://samtools.sourceforge.net/ and unpacked into the
SAM tools source directory. The SAM tools were built according to the manual.
2.2.3 Tophat
Tophat software was downloaded from http://tophat.cbcb.umd.edu/downloads/ and installed.
2.2.4 Cufflinks (Trapnell,etal.,2010)
Cufflinks software was downloaded from http://cufflinks.cbcb.umd.edu/downloads/ and
installed.
2.2.5 Reference genome
Reference genome indices and annotation files were used for the analysis with Tophat and
Cufflinks. The reference genome files were downloaded for the Homo sapiens hg19 build from
ftp://igenome:G3nom3s4u@ftp.illumina.com/Homo_sapiens/UCSC/hg19/.

2.3 PROTOCOL
The protocol starts with the mapping of the RNA-Seq reads from each time point to the reference
genome using Tophat. The next step is the transcript assembly. We adopted the approach of a
reference annotation based transcript assembly called the Reference Annotation Based Transcript
(RABT) assembly using Cufflinks (Roberts, et al., 2011). First, Cufflinks generates aligned fauxreads from the reference transcripts such that every reference transcript position was covered by
multiple reads. In the second step, Cufflinks creates a parsimonious assembly of transfrags
(transcript fragments) by merging both the sequenced reads and the faux-reads. Finally, the
reference transcripts were compared with the assembled transfrags from the second step and
filtered to remove repeats. An assembled transfrag was considered to be novel only if it was not
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removed during the filtering step. Now we have the transcriptome assembly for each time point.
These individual assemblies are then merged parsimoniously using a program called Cuffmerge.
The final step uses a program called Cuffdiff which calculates significant changes in expression
between samples at the level of transcripts, primary transcripts and genes. The final output is
used for downstream statistical analysis to obtain a set of novel genes and transcripts that are
differentially expressed between the time points.

Tophat
Aligns RNA-Seq reads to reference genome

Cufflinks – RABT Assembly
Assembles reads to reference and novel transcripts

Cuffmerge
Parsimoniously merges assemblies of 11 time points

Cuffdiff
Finds differentially expressed genes and transcripts
between different time points

Filtering algorithm to remove artifacts and noise

Correlation with well-annotated genes known to be
important in immunity
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Set of novel genes and transcripts with observed
change in expression due to vaccination

Figure 2.1: An overview of the protocol

2.3.1 Align RNA-Seq reads using Tophat

Read alignment is the first step of RNA-Seq analysis. RNA-Seq generates millions of short
sequence fragments called „short reads‟ in a single experimental run. These reads need to be
aligned to the reference genome in order to measure levels of gene expression or to identify any
novel transcript variants. Gene expression can be measured by estimating the depth of coverage
in the read mapping. There are many bioinformatics tools available for this purpose. One of the
main concerns with RNA-Seq over conventional methods is that the sequenced reads are shorter
and mapping of millions of short reads to the reference genome is a demanding task. Also, most
of the current tools rely on known splice junctions in the genome and cannot identify novel
transcripts.
Tophat (Trapnell, et al., 2009) is an open source, fast splice junction mapping tool that aligns
RNA-Seq reads to a genome and then analyses the mapping for transcript splice sites. It was
originally designed to align the reads that are produced from the Illumina Genome Analyzer
though it has been used successfully for other technologies as well. The program is implemented
in C++ and Python and runs on Linux and OS X. Tophat is built on the ultrafast short read
mapping program called Bowtie. Bowtie aligns the reads to the reference genome at a rate of
tens of millions of reads per CPU hour. But it cannot align reads that span introns and hence
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Tophat was developed to address this limitation. Tophat can align reads to the mammalian
genome at the rate of ~2.2 million reads per CPU hour.
2.3.1.1 Working of Tophat

The Tophat workflow consists of two phases. It first maps the reads to the whole genome using
Bowtie (Langmead, et al., 2009). Bowtie indexes the reference genome using a memory efficient
scheme called a Burrows Wheeler transform (Burrows and Wheeler, 1994; Ferragina and
Manzini, 2001). This enables Bowtie indexes to scan reads against the mammalian genome on a
workstation with around 2 GB RAM. For each read, Bowtie reports one or more alignments
allowing a small number of mismatches (default is two) in the high quality end of the read.
Mismatches are allowed to accommodate genuine differences between the reads and the
reference genome due to sequencing errors. The number of alignments reported by Bowtie can
be controlled by option –k. The default value of k is 10 and all other alignments more than 10 are
suppressed. This helps in excluding alignment of failed reads to low-complexity regions. Tophat
then assembles the mapped reads into a consensus sequence and infers islands of contiguous
sequences as putative exons. It generates possible splice sites between neighboring exons.

Tophat then creates a list of „initially unmappable reads‟ (IUM) from the reads that do not map
to the genome using Bowtie. It breaks up the IUM into smaller pieces called “segments”. Each
segment is checked against the list of possible introns to identify reads that span the splice
junction. Most of these segments align independently across the genome. When Tophat finds
segments of a read that map to possible splices, it infers that the read spans a splice junction and
builds an index of splice sites. By default, Tophat accepts only spans that are longer than 70bp
and shorter than 500,000bp as introns. Tophat allows reads to map to multiple locations in the
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genome and reports the multiple alignments (default maximum is 20).

It suppresses all

alignments of reads that are more than this number (Trapnell, et al., 2012).
The alignment of reads across the genome is helpful in identifying polymorphisms between the
sample and the reference genome. Reads that align to the unannotated part of the genome could
be potential novel regions. Alignments can also be used for the quantification of genes and
transcript expression. The number of reads that align to a transcript is proportional to the
transcript‟s abundance.

Figure 2.2: Tophat workflow (Trapnell, et al., 2009)
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2.3.1.2 Usage

The following command was used to run Tophat on the sequenced reads.
TOPHAT -p 6 -G <REFERENCE_ANNOTATION.GTF> --SOLEXA1.3-QUALS -O <OUTPUT_FILE>
<INDEX_FILE> <INPUT_FILE.FASTQ>

Parameter

Description

Input file 1

Genome index file

Input file 2

Read sequences in FASTQ format

-p <int>

Use this many threads to align reads

-G <GTF file>

Supply gene annotation file or known transcripts

--solexa1.3-quals

Indicates that quality scores are encoded in Solexa FASTQ format

-o <output_dir>

The name of the output directory where Tophat will write its output

Table 2.1: Tophat parameters used in the analysis
Script

When a genome annotation file is given, Tophat will first use Bowtie to align the reads to the
transcripts in this transcriptome. Only the genes that do not fully map to the reference transcripts
are mapped on the genome. The Tophat script produces a number of files in the specified output
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directory. We are interested particularly in the accepted_hits.bam file. This file contains the list
of read alignments in BAM format. This is the input file for the Cufflinks software for transcript
assembly.
2.3.2 Assemble transcripts for each time point using Cufflinks

Cufflinks (Trapnell, et al., May 2010) is an open source assembler that assembles aligned RNASeq reads into transcripts and estimates the abundance of the transcripts. Cufflinks can be used to
annotate a new genome or it can also be used to find new genes and splice variants of known
genes. The program in written in C++ and is freely available in both source code and binary
formats. Cufflinks is a memory intensive program which can be run on both Linux and Mac OS.
The Cufflinks algorithm starts with an input of reads aligned to the genome from software like
Tophat. The input alignment files can either be in BAM or SAM format. Cufflinks first divides
the fragment reads into non-overlapping loci. It then assembles each locus independently as
“bundles” of fragment read alignments that overlap with each other. The bundles are usually
alignments from very few genes. The algorithm estimates the abundance of the assembled
transcripts from the depth of coverage. In the first step of fragment assembly, the fragment
alignments are connected in an overlap graph G. Each fragment is a node in the graph and an
edge from left to right is placed between the nodes say x and y when a) the alignment of x starts
at a lower coordinate than y b) the fragment alignments in the nodes were compatible and c)
overlapping in the genome. It then identifies the „incompatible‟ fragments of the graph which
could be from different splice isoforms. The remaining fragments may have come from any of
the splice isoforms. The path that minimally covers the overlap graph to sets of mutually
compatible fragments is then merged to form different isoforms. Cufflinks implements

16
Dilworth‟s theorem that states that “the number of mutually incompatible fragments in an
overlap graph is the same as the minimum set of paths (transcripts) that are needed to explain all
the fragments”.

Figure 2.3: Cufflinks workflow (Trapnell, et al., May 2010)
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2.3.2.1 Reference annotation based transcript assembly (RABT)

Figure 2.4: RABT assembly (Trapnell, et al., 2012)

The RABT assembly algorithm (Trapnell, et al., 2012) uses a reference annotation to leverage
existing annotation and rapidly discover novel transcripts. The first step in the algorithm is the
mapping of the sequencing reads to the reference genome using a mapping tool like Tophat. The
algorithm also generates “faux-reads” along the reference transcripts. These reads are generated
and tiled in such a way that every position in reference transcript was covered by multiple reads.
Generally, the length of these faux reads is based on the read length and the properties of the
transcriptome. The Cufflinks assembler then parsimoniously assembles the mapped sequenced
reads and the faux reads that contains a minimum number of transcript fragments or transfrags.
The faux-read assembly and the sequenced read assembly are merged. The set of transfrags from
both the assemblies are then compared and the repetitive transfrags were filtered from the
resulting set. The repetitive transfrags were identified using the filtering criteria. The resultant set
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contains all reference annotation transcripts as well as novel transcripts. The RABT assembly
can be used in the Cufflinks assembler by specifying the –g option. This option takes in a gene
annotation file and uses this file as the reference annotation.
2.3.2.2 Usage

The following command was used to run Cufflinks on the aligned reads for Subject 1:
CUFFLINKS -p 7 -g <REFERENCE_ANNOTATION.GTF> -u -o <OUTPUT_DIR>
<ALIGNED_READS>
The following command was used to run Cufflinks on the aligned reads for Subjects 2 and 3:
CUFFLINKS -p 7 -G <REFERENCE_ANNOTATION_FROM_SUBJECT1.GTF> -u -o
<OUTPUT_DIR> <ALIGNED_READS>
Parameter

Description

Input file

The aligned reads from Tophat in SAM/BAM format

-p <int>

Use this many threads to assemble transcripts

-g <GTF file>

Use the supplied gene annotation file for RABT assembly

-G <GTF file>

Use the supplied gene annotation file to report transcripts that are only
compatible with any reference transcript. Novel transcripts are not assembled.

-b <genome .fa>

Use the multifasta file for fragment bias correction

-u

Tells Cufflinks to do multi-read correct for reads mapping to multiple locations

-o <output_dir>

The name of the output directory where Cufflinks will write its output

Table 2.2: Cufflinks parameters used in analysis
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Script for Subject1

Script for Subject2 and 3

Cufflinks assembles individual transcripts from the read alignments through the RABT assembly
specified by the –g option. Subject 1 was supplied the hg19 reference gene annotation file
(genes.gtf) and was assembled using the RABT assembly. This assembly reports both reference
transcripts and novel transcripts. For subjects 2 and 3, we supplied the gene annotation file from
Subject 1 (merged.gtf) that was generated from the Cuffmerge utility. The transcripts were
assembled with –G option where it only reports transcripts compatible with the reference
transcripts of Subject 1. It does not report any novel transcript. Cufflinks produces three output
files: 1) transcripts.gtf contains the assembled transcripts 2) isoforms.fpkm_tracking contains the
estimated isoform-level expression 3) genes.fpkm_tracking contains the estimated gene-level
expression. The transcripts.gtf from each sample is the input for the Cuffmerge utility.
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2.3.3 Merge individual assemblies using Cuffmerge
Cuffmerge is a “meta-assembler” that assembles the individual assemblies from Cufflinks
parsimoniously, the way Cufflinks handles the mapped reads from Tophat (Trapnell, et al.,
2012). This utility comes with the Cufflinks package. Cuffmerge also performs a RABT
assembly to merge the reference transcripts with the sequenced read transcripts to create a single
annotation file that is used by Cuffdiff for downstream differential analysis.
Once Cufflinks has assembled the mapped reads on each time point from day 0 to day 10 to
individual assemblies, the output file transcript.gtf is created for each sample. Cuffmerge takes
these files as input and merges them to create a merged gene annotation file. Merging the
assemblies helps better cover the transcripts with insufficient sequencing depth.

Figure 2.5: Cuffmerge assembly
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2.3.3.1 Usage

The following command was used to merge the individual assemblies from Cufflinks to a single
merged transcriptome annotation:
CUFFMERGE -g <REFERENCE_ANNOTATION.GTF> -s <GENOME_FASTA_FILE>
-p 7

-o <OUTPUT_DIR> <ASSEMBLY_GTF_LIST.TXT>

Parameter

Description

Input file

The list of transcripts.gtf files of samples to be merged

-p <int>

Use this many threads

-g <GTF file>

Use the supplied reference annotation during merge

-s <ref_seq>

Use the genomic reference FASTA files

-o <output_dir>

The name of the output directory where Cufflinks will write its output

Table 2.3: Cuffmerge parameters used in the analysis
Script
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The Cuffmerge utility merges all the individual assemblies from the sample to produce the
merged.gtf that contains the merged assembly. This file is the input for the differential analysis
of gene expression using Cuffdiff.
2.3.4 Identify differentially expressed genes and transcripts using Cuffdiff
After mapping the RNA-sequenced reads to the genome, assembling them into transcripts and
merging the individual assemblies, the next step is to find differentially expressed genes and
transcripts. The Cuffdiff utility calculates the gene and transcript expression levels in two or
more conditions and tests them for statistical significance (Trapnell, et al., 2012). It also reports
a) genes that are differentially regulated via promoter switching b) genes that are differently
spliced in different conditions c) genes with differential protein output d) splicing preference
with among genes with same Transcription start site (TSS) and e) differential regulation of genes
with different TSS (Fig 2.6).

Cuffdiff calculates the changes in expression values using the Cufflinks transcript quantification
engine. The statistical model that is used assumes that the number of reads produced by each
transcript is directly proportional to transcript abundance. But there could be a bias because of
the technical variability introduced by library preparation and sequencing or biological
variability between replicates. Generally RNA-Seq has substantially less technical variability
than gene expression microarrays. For biological variability, when biological replicates are
provided for each condition, Cuffdiff learns the RNA-Seq read distribution across the replicates.
It uses these variance estimates to calculate the significance of differential expression (Trapnell,
et al., 2012).
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Figure 2.6: Identify differently regulated genes using Cuffdiff

2.3.4.1 Usage

The following command was used to do differential analysis of gene expression using Cuffdiff:
CUFFDIFF -p 7 -o <OUTPUT_DIR> -T -u -b <GENOME.FASTA> -L
<LABEL1,LABEL2…..LABELN> <MERGED_ASSEMBLY.GTF>
<ACCEPTED_HITS1.BAM ACCEPTED_HITS2.BAM……. ACCEPTED_HITSN.BAM>
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Parameter

Description

Input file 1

The merged transcript annotation file from Cuffmerge

Input file 2

Read alignment file in BAM format

-p <int>

Use this many threads

-T

Analyze samples as time series

-u

Tells Cufflinks to do multi-read correct

-L

Specify a label for each sample

-b<genome.fa>

Use the genomic reference FASTA files

-o <output_dir>

The name of the output directory where Cufflinks will write its output

Table 2.4: Cuffdiff parameters used in the analysis
Script

Cuffdiff takes as input the merged annotation file from Cuffmerge and the read alignment files of
more than one sample from Tophat. It produces a number of output files that contain the
differences in expression levels for transcripts, primary transcripts, genes and coding sequences.
It calculates the number of fragments per kilobase of exon per million mapped fragments
(FPKM) for each transcript, primary transcript and gene in each sample and outputs them as
FPKM tracking files. It also outputs an estimate of the number of fragments from each transcript,
primary transcript and gene for each sample.
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2.3.5 Downstream Analysis Algorithm
Genes.fpkm.tracking file from Cuffdiff output

Genes with only one transcript

Genes that are not annotated

Genes with max FPKM >= 5 (Subject 1) or >= 3 (Subjects 2 and 3)

Genes with max fold change >2 and min fold change < 0.5

Genes with no overlap with known annotated genes

Genes that correlate well with 28 PCR targets
Figure 2.7: Downstream analysis algorithm

2.3.5.1 Genes.fpkm.tracking
The genes.fpkm.tracking file from Cuffdiff is used for further downstream analysis. This file
reports the FPKM and the significance values (confidence values) of each gene in each time
point from d0 to d10. The FPKM of the genes is calculated as the sum of FPKM of all transcripts
sharing the same gene id. It also reports the gene name if any and all the TSS of the gene. The
following snapshot shows the structure of the genes.fpkm.tracking file. The first line is the
header line followed by data.
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2.3.5.2 Genes with only one transcript:
We first filtered out the genes with more than one Transcription Start site (TSS). This was done
to make the analysis simpler. Information about TSS is available in the tss_id (column 6) of the
genes.fpkm.tracking file. When there is more than one TSS, they are all listed in the id column
separated by comma. This column was processed to include those genes that had only one TSS.
2.3.5.3 Genes with no gene name
The next step was to identify the genes that were not annotated with a gene name. This data is
found in the gene_short_name column (column 5) of the genes.fpkm.tracking file. When there
was no gene name available, the gene_short_name column had “-“ as value. This column was
processed to include those genes that had a “-“ in the gene_short_name column.
2.3.5.4 Genes with max FPKM >=5 or >= 3

This step only selects for those genes that have enough numbers of reads i.e., good depth of
coverage in at least one sample. Depth of coverage was determined using the max FPKM
parameter. Max FPKM is the maximum of the FPKM values from day 0 to day 10. This value
was calculated for the genes from step3 and a cut-off of 5 was applied for subject1 and a cut-off
of 3 was applied for subject 2 and subject 3. The values „3‟ and „5‟ for max FPKM were chosen
to control the number of resultant genes that are subjected to further filtering.
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2.3.5.5 Genes with max fold change >2 and min fold change < 0.5
This step only selects for genes that show a change in expression level (fold change) as an effect
of vaccination. The fold change is the ratio of the FPKM from days 1 till 10 to day 0 (d1:d0,
d2:d0, d3:d0, etc.). The ratio was calculated for all genes and the maximum and the minimum
fold change for each gene was determined. The most interesting genes were the ones with a two
fold increase or decrease in expression levels. Hence the genes with either max fold change > 2
or min fold change less than 0.5 were selected.
2.3.5.6 Genes with no overlap with known annotated genes
This step only selects for genes that do not overlap with any annotated genes. The known gene
table of hg19 from UCSC was used for this analysis. All genes that overlapped with known
genes were filtered out.
2.3.5.7 Genes that correlate (positive or negative) with important genes in immunity

This step calculates the Pearson correlation r of the short listed genes from step 6 with 28 wellannotated genes that are known to be important in immunity. These genes were selected by the
URMC immunologists based on the initial RNA Seq analysis done by Dr. Hulin Wu's group at
the URMC biostatistics department. They were selected from a larger group of over 700 genes
that were affected by the vaccine in all 3 subjects. The 28 genes that were used in the analysis are
FCRLA, GFI1, FAM171A1, CD5, CD59, CD27, AICDA, CIITA, ITGAM, IRF8, JUP, FCER2,
POU2F2, SDC1, FER1L4, XBP1, BCL6, CD38, SEL1L3, DDX60L, CASP3, CD74, IRF4,
PRDM1, BACH2, BHLHA15, TNFRSF10B and PAX5. The FPKMs of the well-annotated
genes were obtained from the original genes.fpkm.tracking file of each subject. A correlation
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matrix was drawn and only those genes that had at least 80% correlation with at least one wellannotated immunity gene were selected.
These seven steps were done for every subject and all the genes that satisfied the filters
comprised the final list. The final gene list from all subjects was compared and only those that
were common in 2 or more subjects were chosen for further investigation.
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3 RESULTS AND DISCUSSION
The FASTQ files of each time point (day 0 to day 10) for subjects 1, 2 and 3 were used by
Tophat to align the sequenced reads to the reference genome. The read alignment BAM files of
each time point from Tophat were used by Cufflinks to assemble them into reference transcripts
and novel transcripts using RABT assembly. The transcript assemblies of all time-points for each
subject were merged into a single gene annotation by Cuffmerge. Cuffdiff reported the change in
expression levels of the genes at all time points in the genes.fpkm.tracking file. This file was
used for further downstream analysis. These genes were filtered using the filtering algorithm to
only select for the novel genes that are affected by immunization and has a good correlation with
well annotated genes known to be important in immunity.
Step

Description

Subject 1

Subject 2

Subject3

1

Genes in genes.fpkm.tracking file

26040

25580

25580

2

Genes with one TSS

19432

18990

18990

3

Non-annotated genes

1862

1198

1198

4

Genes with max FPKM
>=5 or >=3
Genes with max fold change >=2 or min
<=0.5
Genes with no overlap with known genes

795

433

644

628

263

377

503

236

338

Genes with at least 80% correlation with
important genes in immunity

70

18

29

5
6
7

Table 3.1: Effect of filters in downstream analysis
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Figure 3.1: Effect of filters in downstream analysis
Table 3.1 and Figure 3.1 show the results from applying different filters in the
downstream analysis. There were 70, 18 and 29 candidate “novel” genes in subjects 1, 2 and 3
respectively. When comparing the resultant set of all three subjects, there were 5 genes that were
common in 2 or more subjects. Three genes were common in all 3 subjects and two of them were
common in 2 subjects. The five genes and their locations are listed in Table 3.2. These five genes
were the candidates for further investigation.
Gene

Chr

Start

End

Subjects

1

chr12

68727015

68727534

All 3

2

chr22

22712670

22713033

All 3

3

chrX

39646217

39646420

All 3

4

chr14

21127296

21128294

2/3

5

chr7

138706842

138707542

2/3

Table 3.2: The five candidate genes
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The expression levels (FPKM) of the 5 genes were analyzed in each subject across all time
points. All genes expressed a significant increase in expression in days 5, 6, 7 when compared to
day 0 in 2 or more subjects (Fig 3.2). For genes 4 and 5, which were common only in 2 out of 3
subjects, gene 5 did not show similar trend of increased expression in subject 2 like in subjects 1
and 3.

Figure 3.2: Distribution of FPKM of candidate genes in subjects 1,2 and 3
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Figure 3.2 shows the change in expression of the 5 genes in subject 1, 2 and 3 across all time
points. Since gene 5 does not show a similar trend, it was not included for further investigation.
The sequences of the remaining four genes (genes 1, 2, 3 and 4) were retrieved and a nucleotide
blast (blastn) against reference RNA database was done to search for matching annotated
transcripts. The BLAST results revealed that gene 3 is highly similar to glyceraldehyde-3phosphate dehydrogenase (GAPDH) variants suggesting that gene 3 could be part of a GAPDH
transcript variant (Fig 3.3). Since this GAPDH variant is not interesting in terms of immune
response, this gene was not considered important.

Figure 3.3: blastn hits for gene 3
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When the remaining 3 genes were viewed in the UCSC genome browser, the human mRNAs
track revealed that gene 2 overlapped with a number of immunoglobulin light chain variable
transcripts (Fig 3.4). It is not surprising that immunoglobulin light chain locus is affected by
vaccination.

Figure 3.4: View of gene 2 on UCSC genome browser
The final 2 genes (gene 1 and gene4) were subjected to further exploration. The RNASeq aligned reads from Tophat (accepted_hits.bam file) of the baseline and the peak time points
of all subjects were plotted on IGV (Integrative Genomics Viewer) browser (Fig 3.5 and Fig
3.6). Samtools was used to index the bam files from Tophat to create the bam index file (.bai)
that is needed to view the reads on IGV. The IGV browser helps to view the reads in the regions
upstream and downstream of the genes. This would help to understand if the increase of
expression in the 2 “novel” genes is because of the presence of neighboring well-characterized
transcripts that are up-regulated by vaccination. This is because the productive up regulation of
the expression of a gene can affect the nearby regions that are not specifically regulated by the
immune system.
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Figure 3.5: Plot of final gene 1 on IGV

Figure 3.6: Plot of final gene 2 on IGV
MDM1 and IL22 were the only annotated genes that were found within 100,000bp radius
upstream and downstream of gene 1. A close look at the expression levels of MDM1 and IL22
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shows that these genes are not affected by immunization (Fig 3.7). Hence gene 1 appears to be
up-regulated in immunization without the effect of nearby regions.

Figure 3.7: Distribution of FPKM of MDM1 and IL22
There were 6 genes, RNASE9, RNASE11, OR6S1, ANG, RNASE4 and EDDM3A that
were present within 100,000bp upstream and downstream of gene 2. Genes RNASE9,
RNASE11, OR6S1 and EDDM3A had very little or no reads aligned against them.
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Figure 3.8: Distribution of FPKM of ANG and RNASE4 (overlapping genes)
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Genes ANG and RNASE4 overlap with each other. ANG and RNASE4 have an increase in
expression levels in days 6, 7 when compared to day 0 in subjects 1 and 2 only, though this trend
is not observed in subject 3 (Fig 3.8). This suggests that the up-regulation of our novel gene 2
might be influenced by genes ANG and RNASE4.
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4 CONCLUSION
RNA-sequencing was used to understand the transcriptional response of B-cells in patients post
flu vaccination. The software tools combined with the downstream analysis led to the discovery
of two potentially novel genes. The up-regulation of novel gene 1 due to vaccination appears to
be independent of nearby well-characterized regions. Gene 2 might be coincidentally regulated
by transcription factors that regulate the neighboring genes ANG and RNASE4. However, there
is not enough evidence that the two candidates are not novel genes affected by vaccination. The
function of the genes could not be determined as the potential translated product from these
genes that were identified using ORF Finder and blastp did not have high similarity with known
proteins. Nevertheless, the genes could be functional as non-coding RNA. Further research
would have to be done in order determine and validate the function of the genes.
The downstream analysis in this study concentrates only on the genes and transcripts that are
commonly regulated in all 3 subjects. Though these genes are the most interesting, immune
response between subjects might vary due to various factors. The results could be further
explored to see why potential novel genes from one subject are missing from others. The
downstream analysis algorithm has numerical filters whose values were set arbitrarily. There is a
chance that some interesting genes could be filtered by one of our numerical filters like max
FPKM or fold change. The other limitation is that since only poly-A mRNA is used in the study,
it would be interesting to see if there is any 3‟end bias and if there is any loss of information on
the 5‟ end.
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